Global microRNA depletion suppresses tumor angiogenesis.

PubWeight™: 1.76‹?› | Rank: Top 3%

🔗 View Article (PMC 4035535)

Published in Genes Dev on May 01, 2014

Authors

Sidi Chen1, Yuan Xue2, Xuebing Wu3, Cong Le4, Arjun Bhutkar2, Eric L Bell5, Feng Zhang4, Robert Langer6, Phillip A Sharp7

Author Affiliations

1: Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts 02142, USA;
2: Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA;
3: Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA; Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA;
4: Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts 02142, USA;
5: Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA;
6: Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
7: Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA;

Articles citing this

CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell (2014) 3.68

Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell (2015) 3.58

CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature (2014) 3.28

miRNA Deregulation in Cancer Cells and the Tumor Microenvironment. Cancer Discov (2016) 1.03

Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery. Nat Methods (2015) 0.96

A versatile reporter system for CRISPR-mediated chromosomal rearrangements. Genome Biol (2015) 0.86

miR-125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway. Oncol Lett (2015) 0.85

Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma. Acta Pharmacol Sin (2015) 0.84

Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer. Oncotarget (2015) 0.83

MicroRNA aberrations: An emerging field for gallbladder cancer management. World J Gastroenterol (2016) 0.81

Argonaute 2: A Novel Rising Star in Cancer Research. J Cancer (2015) 0.80

Tiny giants of gene regulation: experimental strategies for microRNA functional studies. Wiley Interdiscip Rev Dev Biol (2016) 0.80

MicroRNA profiling in intraocular medulloepitheliomas. PLoS One (2015) 0.79

Targeting noncoding RNAs in disease. J Clin Invest (2017) 0.78

Hypoxia: micro changes. Nat Rev Cancer (2014) 0.75

AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma. Nat Neurosci (2017) 0.75

Articles cited by this

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87

MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17

NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41

TopHat: discovering splice junctions with RNA-Seq. Bioinformatics (2009) 81.13

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol (2010) 75.21

MicroRNA expression profiles classify human cancers. Nature (2005) 69.12

Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53

RNA-guided human genome engineering via Cas9. Science (2013) 48.29

A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21

Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell (1999) 32.32

TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res (2003) 29.26

Angiogenesis in cancer and other diseases. Nature (2000) 28.28

Targeting HIF-1 for cancer therapy. Nat Rev Cancer (2003) 28.01

miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A (2005) 21.51

A uniform system for microRNA annotation. RNA (2003) 20.28

DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol (2013) 19.99

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res (2004) 18.86

BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods (2009) 18.41

Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (1989) 16.71

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res (2012) 15.90

Dicer is essential for mouse development. Nat Genet (2003) 15.87

Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet (2007) 15.46

CellProfiler: free, versatile software for automated biological image analysis. Biotechniques (2007) 14.71

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell (2008) 13.49

Comprehensive comparative analysis of strand-specific RNA sequencing methods. Nat Methods (2010) 9.09

Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol (2004) 9.05

Molecular signatures database (MSigDB) 3.0. Bioinformatics (2011) 8.08

Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature (2011) 7.94

MicroRNA-cancer connection: the beginning of a new tale. Cancer Res (2006) 7.38

FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev (2002) 7.08

Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A (2008) 6.89

FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev (2001) 6.35

Roles for microRNAs in conferring robustness to biological processes. Cell (2012) 6.32

Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev (2009) 5.21

Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res (2007) 5.09

MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem (2008) 4.69

Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc (2009) 4.50

The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer (2008) 4.42

Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem (2004) 4.40

MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One (2006) 4.29

Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A (2008) 3.03

EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature (2013) 2.67

Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. J Cell Sci (2003) 2.46

MicroRNAs as novel regulators of angiogenesis. Circ Res (2009) 2.33

Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med (2011) 2.25

Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J (2012) 2.21

miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res (2010) 2.18

Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem (2003) 2.11

Proliferation and tumorigenesis of a murine sarcoma cell line in the absence of DICER1. Cancer Cell (2012) 2.04

Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. Cancer Res (1976) 2.03

Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc Natl Acad Sci U S A (2008) 1.93

Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation. Nat Cell Biol (2012) 1.89

The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Cancer Res (2006) 1.75

The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism. Cell Metab (2010) 1.64

Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803. Biochem J (2002) 1.61

Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol (2012) 1.41

PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells. Nat Med (2011) 1.33

Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis. J Clin Invest (2013) 1.30

A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like. Mol Cell Biol (2011) 1.26

Measuring Tumor Hypoxia. Semin Radiat Oncol (1996) 1.22

In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs. RNA (2012) 1.20

Differences in hydroxylation and binding of Notch and HIF-1alpha demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1). Int J Biochem Cell Biol (2009) 1.03

Transforming growth factor β-regulated microRNA-29a promotes angiogenesis through targeting the phosphatase and tensin homolog in endothelium. J Biol Chem (2013) 0.99

Adipose angiogenesis: quantitative methods to study microvessel growth, regression and remodeling in vivo. Nat Protoc (2010) 0.92

Let-7 represses Nr6a1 and a mid-gestation developmental program in adult fibroblasts. Genes Dev (2013) 0.91

Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2). J Cell Sci (2013) 0.86